Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Exchange Rate Effect of $819522.0 for Q1 2026, up 159.98% year-over-year from $315228.9 in Q1 2025, and up 152.27% quarter-over-quarter from -$1.6 million in Q4 2025.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Exchange Rate Effect for 11 consecutive years, with $819522.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 159.98% year-over-year to $819522.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 45519.78% YoY), while the FY2025 annual figure was -$5.2 million, down 372.39% from the prior year.
- Exchange Rate Effect advanced to $819522.0 in Q1 2026 per LKFT's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $18.4 million in Q1 2022 and bottomed at -$3.8 million in Q4 2022.
- Historically, Exchange Rate Effect has averaged $848382.8 across 5 years, with a median of -$272628.8 in 2023.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect soared 298.84% — and 2025, when it tumbled 511.86%.
- Lakefront Biotherapeutics' Exchange Rate Effect stood at -$3.8 million in 2022, then surged by 74.15% to -$984485.0 in 2023, then surged by 244.25% to $1.4 million in 2024, then tumbled by 210.41% to -$1.6 million in 2025, then surged by 152.27% to $819522.0 in 2026.
- Business Quant data shows LKFT's Exchange Rate Effect at $819522.0 in Q1 2026, -$1.6 million in Q4 2025, and -$100538.7 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 819,521.96 |
| Dec 31, 2025 | -1.57 Mn |
| Sep 30, 2025 | -100,538.74 |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -533,734.68 |
| Jun 30, 2024 | 473,830.53 |
| Mar 31, 2024 | 542,094.52 |
| Dec 31, 2023 | -1.64 Mn |
| Mar 31, 2023 | -272,628.82 |
| Dec 31, 2022 | -3.81 Mn |
| Mar 31, 2022 | 18.36 Mn |
| Jun 30, 2021 | -11.60 Mn |
| Mar 31, 2021 | 38.30 Mn |
| Dec 31, 2020 | -84.10 Mn |
| Dec 31, 2019 | -11.03 Mn |
| Jun 30, 2019 | -3.49 Mn |
| Mar 31, 2019 | 5.65 Mn |
| Dec 31, 2018 | 11.51 Bn |